Placebo | Supplemented | RR (95% CI) | p-value | |
---|---|---|---|---|
Number of fever episodes (mean ± SD) | 2.04 ± 1.2 | 1.63 ± 1.2 | - | 0.038 |
Number of malaria episodes (mean ± SD) | 1.5 ± 1.005 | 1 ± 0.93 | - | 0.029 |
P*PFever episodes | 153 | 119 | 1.28 (1.09–2.94) | 0.030 |
P*PMalaria episodes | 106 | 74 | 1.43 (1.10–2.40) | 0.025 |
Free of pathologies | 17% (9–25) | 31% (16–46) | - | 0.05 |
Cough episodes | 51,3 (40–62.6) | 45,9% (34.6–57.2) | - | 0.510 |
Diarrhea episodes | 52,7% (41.4–64) | 28,3% (18.1–38.5) | - | 0.002 |
Geometric mean density P falciparum (asexual forms/μl) | 10672 (7589–15007) | 7704 (5409–10971) | - | 0.049 |